$395.48
2.38[0.61%]
Last update: 3:30PM Get Real Time Here
Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | VRTX | Q1 | $3.05 | $4.02 | — | — | $2.38B | $2.57B | — | — | Get Alert |
02/05/2024 | PM | VRTX | Q4 | $3.76 | $4.10 | $4.20 | 2.44% | $2.30B | $2.51B | $2.52B | 0.31% | Get Alert |
11/06/2023 | PM | VRTX | Q3 | $4.01 | $3.98 | $4.08 | 2.51% | $2.33B | $2.50B | $2.48B | -0.64% | Get Alert |
08/01/2023 | PM | VRTX | Q2 | $3.60 | $3.85 | $3.89 | 1.04% | $2.20B | $2.41B | $2.49B | 3.44% | Get Alert |
05/01/2023 | PM | VRTX | Q1 | $3.52 | $3.00 | $3.05 | 1.67% | $2.10B | $2.34B | $2.38B | 1.50% | Get Alert |
02/07/2023 | PM | VRTX | Q4 | $3.37 | $3.51 | $3.76 | 7.12% | $2.07B | $2.30B | $2.30B | 0.13% | Get Alert |
10/27/2022 | PM | VRTX | Q3 | $3.56 | $3.67 | $4.01 | 9.26% | $1.98B | $2.23B | $2.33B | 4.66% | Get Alert |
08/04/2022 | PM | VRTX | Q2 | $3.11 | $3.52 | $3.60 | 2.27% | $1.79B | $2.13B | $2.20B | 3.10% | Get Alert |
05/05/2022 | PM | VRTX | Q1 | $2.98 | $3.49 | $3.52 | 0.86% | $1.72B | $2.08B | $2.10B | 0.82% | Get Alert |
01/26/2022 | PM | VRTX | Q4 | $2.51 | $3.29 | $3.37 | 2.43% | $1.63B | $2.00B | $2.07B | 3.65% | Get Alert |
11/02/2021 | PM | VRTX | Q3 | $2.64 | $3.08 | $3.56 | 15.58% | $1.54B | $1.86B | $1.98B | 6.67% | Get Alert |
07/29/2021 | PM | VRTX | Q2 | $2.61 | $2.28 | $3.11 | 36.40% | $1.52B | $1.72B | $1.79B | 4.24% | Get Alert |
04/29/2021 | PM | VRTX | Q1 | $2.56 | $2.69 | $2.98 | 10.78% | $1.51B | $1.66B | $1.72B | 3.86% | Get Alert |
02/01/2021 | PM | VRTX | Q4 | $1.70 | $2.59 | $2.51 | -3.09% | $1.26B | $1.58B | $1.63B | 3.04% | Get Alert |
10/29/2020 | PM | VRTX | Q3 | $1.23 | $2.32 | $2.64 | 13.79% | $949.83M | $1.47B | $1.54B | 4.63% | Get Alert |
07/30/2020 | PM | VRTX | Q2 | $1.26 | $2.07 | $2.61 | 26.09% | $941.28M | $1.39B | $1.52B | 9.64% | Get Alert |
04/29/2020 | PM | VRTX | Q1 | $1.14 | $1.84 | $2.56 | 39.13% | $858.29M | $1.29B | $1.51B | 17.44% | Get Alert |
01/30/2020 | PM | VRTX | Q4 | $1.30 | $1.20 | $1.70 | 41.67% | $869.44M | $1.01B | $1.26B | 24.46% | Get Alert |
10/30/2019 | PM | VRTX | Q3 | $1.09 | $1.13 | $1.23 | 8.85% | $783.86M | $948.76M | $949.83M | 0.11% | Get Alert |
Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 5, 2024 for Q4.
The Actual EPS was $4.20, which beat the estimate of $4.10.
The Actual Revenue was $2.5B, which beat the estimate of $2.5B.
Browse earnings estimates, EPS, and revenue on all stocks.